Kymera Therapeutics Inc (NAS:KYMR)
$ 50.05 -1.84 (-3.55%) Market Cap: 3.24 Bil Enterprise Value: 2.90 Bil PE Ratio: 0 PB Ratio: 3.63 GF Score: 47/100

Q3 2023 Kymera Therapeutics Inc Earnings Call Transcript

Nov 02, 2023 / 12:00PM GMT
Release Date Price: $12.08 (+4.59%)
Operator

Good day, and welcome to the Kymera Therapeutics Third Quarter 2023 Results Call. (Operator Instructions) Please note that this event is being recorded.

I'd like to turn the conference over to Ms. Justine Koenigsberg, Vice President of Investor Relations. Please go ahead.

Justine Koenigsberg

Good morning, and welcome to Kymera's Quarterly Update. Joining me on this morning's call are Nello Mainolfi, Founder, President and CEO; Jared Gollob, our Chief Medical Officer; and Bruce Jacobs, Chief Financial Officer. Following our remarks and presentation, we will open the call to questions. During the Q&A portion of the call, please limit your question to 1 and a related follow-up so that we will have enough time to address everyone's questions.

Please note that we will be referencing slides in our corporate presentation during Jared's remarks. The slides can be accessed in the Investors section of our website, under Events and Presentations, and will be shown during the call for those on the webcast. Before we begin, today's discussion will include

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot